AT354565T

Hydroxyethylamine derivatives for the treatment of alzheimer's disease

Abstract

The invention relates to a Asp2 (β - secretase, BACE1 or Memapsin) of the active novel or more of amine compound and preparation method, comprising these compounds composition and wherein the β for the treatment of a a amyloid layer or β - amyloid film is the disease, and use of Alzheimer's.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

30 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
0228410United KingdomA

Members30

Family members, oldest first
DocumentOfficeKind
GB0228410D0United KingdomD0
CA2508325A1CanadaA1
WO2004050619A1World Intellectual Property Organization (WIPO)A1
AU2003292198A1AustraliaA1
IS7925AIcelandA
NO20053263D0NorwayD0
MXPA05006088AMexicoA
KR20050084143ARepublic of KoreaA
EP1567488A1European Patent Office (EPO)A1
NO20053263LNorwayL
BR0317020ABrazilA
MA27608A1MoroccoA1
RU2005121146ARussian FederationA
US2006025459A1United States of AmericaA1
PL377587A1PolandA1
CN1735592AChinaA
JP2006514634AJapanA
HK1083624A1Hong Kong, ChinaA1
EP1567488B1European Patent Office (EPO)B1
AT354565TThis recordAustriaT
DE60312031D1GermanyD1
PT1567488EPortugalE
DK1567488T3DenmarkT3
US7253198B2United States of AmericaB2
SI1567488T1SloveniaT1
AU2003292198B2AustraliaB2
ES2282685T3SpainT3
DE60312031T2GermanyT2
NZ539841ANew ZealandA
ZA200503693BSouth AfricaB